𝔖 Bobbio Scriptorium
✦   LIBER   ✦

148 - The efficacy of gemcitabine in controlling pain and improving performance status in men with hormone-refractory prostate cancer (HRPC)

✍ Scribed by F.R. Ahmann; H.A. Burris; B. Nguyen

Book ID
117664409
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
261 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 3 randomized controlled trial of
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
✍ Michael A. Carducci; Fred Saad; Per-Anders Abrahamsson; David P. Dearnaley; Clau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the efficacy and safety of atrasentan (Xinlay), a selective endothelin‐A receptor antagonist, in patients with metastatic hormone‐refractory prostate cancer (HRPC). ## METHODS. This multinational, double‐blind, placebo‐contro